FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884967175> ?p ?o ?g. }

• W2884967175 endingPage "269" @default.
• W2884967175 startingPage "261" @default.
• W2884967175 abstract "Abstract Background Infliximab (IFX) is a breakthrough treatment for refractory Crohn’s disease (CD) whose effect on postoperative complications of CD remains controversial. The purpose of this study was to conduct a meta-analysis examining the effect of IFX on postoperative complications of CD. Methods We searched “PubMed,” “EMBASE,” and “Cochrane Library” databases from inception of each database until March 2018. All eligible articles were screened according to the inclusion criteria. The cumulative overall, major, minor, infectious, noninfectious, surgical, and medical complications, as well as reoperation, readmission, and mortality of CD patients who received IFX and underwent ileocolonic resection were extracted and analyzed using Review Manager 5.3. The random effects model was used to calculate the odds ratio (OR) and 95% confidence interval (CI). Results A total of 18 nonrandomized controlled trial studies, with 1407 patients who received IFX and 4589 patients who did not were identified. The incidence of complications was 9.38%–60.56% in the IFX group and 12.73%–53.85% in the control group. Overall, major, minor, infectious, noninfectious, surgical, and medical complications could be assessed in 16, 12, 11, 14, 12, 12, and 11 studies, respectively. There were no statistically significant differences between the 2 groups for any complication (P &gt; 0.05, all comparisons). Reoperation (P = 0.70), readmission (P = 0.22) and mortality (P = 0.86) showed no significant difference between the 2 groups. Subgroup analysis showed that complications were not significantly different among the countries represented in the studies. Conclusions Based on this analysis, there does not appear to be an association between preoperative IFX treatment and postoperative complications of CD; IFX appears relatively safe for preoperative use in the treatment of CD." @default.
• W2884967175 created "2018-08-03" @default.
• W2884967175 creator A5004735881 @default.
• W2884967175 creator A5027631321 @default.
• W2884967175 creator A5027995459 @default.
• W2884967175 creator A5057584690 @default.
• W2884967175 creator A5083531652 @default.
• W2884967175 date "2018-07-24" @default.
• W2884967175 modified "2023-10-17" @default.
• W2884967175 title "Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn’s Disease" @default.
• W2884967175 cites W1557244150 @default.
• W2884967175 cites W1593231251 @default.
• W2884967175 cites W1974442963 @default.
• W2884967175 cites W1989118653 @default.
• W2884967175 cites W1990220938 @default.
• W2884967175 cites W1990864861 @default.
• W2884967175 cites W1995605870 @default.
• W2884967175 cites W1995681414 @default.
• W2884967175 cites W1997106678 @default.
• W2884967175 cites W2006394992 @default.
• W2884967175 cites W2011946356 @default.
• W2884967175 cites W2018073324 @default.
• W2884967175 cites W2030662008 @default.
• W2884967175 cites W2034126900 @default.
• W2884967175 cites W2034536484 @default.
• W2884967175 cites W2035049298 @default.
• W2884967175 cites W2064770992 @default.
• W2884967175 cites W2080410907 @default.
• W2884967175 cites W2082934679 @default.
• W2884967175 cites W2083533774 @default.
• W2884967175 cites W2087088049 @default.
• W2884967175 cites W2093872664 @default.
• W2884967175 cites W2104600285 @default.
• W2884967175 cites W2111570058 @default.
• W2884967175 cites W2119986033 @default.
• W2884967175 cites W2121211166 @default.
• W2884967175 cites W2136580860 @default.
• W2884967175 cites W2144173184 @default.
• W2884967175 cites W2148183537 @default.
• W2884967175 cites W2149733353 @default.
• W2884967175 cites W2254314522 @default.
• W2884967175 cites W2559768415 @default.
• W2884967175 cites W2739452942 @default.
• W2884967175 cites W2780836832 @default.
• W2884967175 doi "https://doi.org/10.1093/ibd/izy246" @default.
• W2884967175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30052982" @default.
• W2884967175 hasPublicationYear "2018" @default.
• W2884967175 type Work @default.
• W2884967175 sameAs 2884967175 @default.
• W2884967175 citedByCount "43" @default.
• W2884967175 countsByYear W28849671752019 @default.
• W2884967175 countsByYear W28849671752020 @default.
• W2884967175 countsByYear W28849671752021 @default.
• W2884967175 countsByYear W28849671752022 @default.
• W2884967175 countsByYear W28849671752023 @default.
• W2884967175 crossrefType "journal-article" @default.
• W2884967175 hasAuthorship W2884967175A5004735881 @default.
• W2884967175 hasAuthorship W2884967175A5027631321 @default.
• W2884967175 hasAuthorship W2884967175A5027995459 @default.
• W2884967175 hasAuthorship W2884967175A5057584690 @default.
• W2884967175 hasAuthorship W2884967175A5083531652 @default.
• W2884967175 hasConcept C120665830 @default.
• W2884967175 hasConcept C121332964 @default.
• W2884967175 hasConcept C126322002 @default.
• W2884967175 hasConcept C141071460 @default.
• W2884967175 hasConcept C156957248 @default.
• W2884967175 hasConcept C168563851 @default.
• W2884967175 hasConcept C187960798 @default.
• W2884967175 hasConcept C197934379 @default.
• W2884967175 hasConcept C2776478404 @default.
• W2884967175 hasConcept C2777138892 @default.
• W2884967175 hasConcept C2779134260 @default.
• W2884967175 hasConcept C2779280984 @default.
• W2884967175 hasConcept C44249647 @default.
• W2884967175 hasConcept C61511704 @default.
• W2884967175 hasConcept C71924100 @default.
• W2884967175 hasConcept C81182388 @default.
• W2884967175 hasConcept C95190672 @default.
• W2884967175 hasConceptScore W2884967175C120665830 @default.
• W2884967175 hasConceptScore W2884967175C121332964 @default.
• W2884967175 hasConceptScore W2884967175C126322002 @default.
• W2884967175 hasConceptScore W2884967175C141071460 @default.
• W2884967175 hasConceptScore W2884967175C156957248 @default.
• W2884967175 hasConceptScore W2884967175C168563851 @default.
• W2884967175 hasConceptScore W2884967175C187960798 @default.
• W2884967175 hasConceptScore W2884967175C197934379 @default.
• W2884967175 hasConceptScore W2884967175C2776478404 @default.
• W2884967175 hasConceptScore W2884967175C2777138892 @default.
• W2884967175 hasConceptScore W2884967175C2779134260 @default.
• W2884967175 hasConceptScore W2884967175C2779280984 @default.
• W2884967175 hasConceptScore W2884967175C44249647 @default.
• W2884967175 hasConceptScore W2884967175C61511704 @default.
• W2884967175 hasConceptScore W2884967175C71924100 @default.
• W2884967175 hasConceptScore W2884967175C81182388 @default.
• W2884967175 hasConceptScore W2884967175C95190672 @default.
• W2884967175 hasIssue "2" @default.
• W2884967175 hasLocation W28849671751 @default.
• W2884967175 hasLocation W28849671752 @default.

• next